Abbott (NYSE: ABT) has received approval in Europe for its updated Cologuard Plus screening test for colorectal cancer, ahead of plans for a phased rollout across the continent.
Heart failure (HF) is a condition in which the heart is not able to pump blood effectively. However, its effects go beyond pumping and circulation. HF is also known to cause a lasting form of innate immune memory in stem cells that synthesize blood and progenitor cells that are present in the bone marrow (BM). This can result in the production of immune cells that promote inflammation and worsen heart function. However, the exact mechanism of this process remained unclear.
A research team from the Faculty of Dentistry at The University of Hong Kong (HKU), working in collaboration with Su Ryon Shin’s group at Brigham and Women’s Hospital, Harvard Medical School, has advanced and preclinically validated a shape-adaptive hydrogel designed for challenging clinical trauma scenarios involving severe bleeding, irregular bone defects and comminuted fractures.
When Dr. Kourosh Parham conceived a first-of-its-kind blood test for tinnitus, he knew further research was needed to confirm a link between a unique ear protein and the common hearing disorder. To validate his theory, the professor of surgery at UConn Health (UCH), Division of Otolaryngology-Head & Neck Surgery, teamed up with fellow UCH physician-scientists to conduct two clinical trials.
Shenzhen, China, Oct. 10, 2026 /PRNewswire/ — Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for non-invasive blood oxygen (SpO2) measurement (Clearance No. K260490).
Newly cleared CraniUS® Plate configuration, designated NeuroPASS 2, adds an opening designed to accommodate an implantable intracranial pressure sensor; issued patent protects the integrated drug delivery architecture at the heart of NeuroPASS 3.
TOLEDO, Ohio, Oct. 7, 2026 /PRNewswire/ — True Indicating, LLC today announced they received FDA clearance of InstaTRU™, an instant biological indicator for steam sterilization cycles that provides results in just 20 seconds. Using spore-based technology, InstaTRU™ confirms the efficacy of a steam sterilization cycle without requiring an incubator or reader.
Inflammatory conditions in the brain, including traumatic brain injury and degenerative diseases like Alzheimer’s, could be targeted with an existing drug thanks to new research that shows it can work in brain cells.
A large study shows that machine-learning clocks based on speech can estimate chronological age and may also offer a window into brain aging, biological aging, cognitive health, cumulative burden and dementia.
AKRON, Ohio, Sept. 22, 2026 /PRNewswire/ — Resivant Medical announced today that the U.S. Patent and Trademark Office has issued Patent No. 12,678,148, covering the novel single-lever, single-handed applicator design at the core of the Cutiva™ PLUS Skin Closure System. The patent protects the mechanism that allows clinicians to start, control, and stop the flow of adhesive using a single lever, without repositioning the hand or device.